dactinomycin has been researched along with melphalan in 178 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 103 (57.87) | 18.7374 |
| 1990's | 12 (6.74) | 18.2507 |
| 2000's | 28 (15.73) | 29.6817 |
| 2010's | 32 (17.98) | 24.3611 |
| 2020's | 3 (1.69) | 2.80 |
| Authors | Studies |
|---|---|
| Hansch, C; Khwaja, TA; Selassie, CD | 1 |
| Barrows, LR; Ireland, CM; Kokoshka, JM | 1 |
| Allen, TM; Audette, GF; Balzarini, J; De Clercq, E; Dimmock, JR; Kandepu, NM; Kowalchuk, TP; Motaganahalli, N; Mykytiuk, PA; Nazarali, AJ; Perjési, P; Prasad, L; Quail, JW; Santos, CL; Szydlowski, J | 1 |
| Allen, TM; Balzarini, J; De Clercq, E; Dimmock, JR; Kandepu, NM; Kowalchuk, TP; LeClerc, R; Motaganahalli, NL; Nazarali, AJ; Prisciak, JS; Pugazhenthi, U; Quail, JW; Santos, CL | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Banerjee, A; Benedict, WF; Gardner, A; Jones, PA | 1 |
| Borisov, VI | 1 |
| Dickson, JA | 1 |
| Casey, AE; Griswold, DP; Prejean, JD; Weisburger, EK; Weisburger, JH; Wood, HB | 1 |
| Bast, RC; Borsos, T; Greene, SL; Ohanian, SH; Rapp, HJ; Segerling, M; Zbar, B | 1 |
| Eneroth, P; Lundström, V; Wiqvist, N | 1 |
| Hammond, CB; Schmidt, HJ; Suciu, TN; Surwit, EA | 1 |
| Sieber, SM | 1 |
| Altman, SJ; Aust, JB; Cruz, AB; Fletcher, WS; Frelick, RW; Hill, GJ; Metter, G; Ramirez, G; Thames, EA | 1 |
| Rutledge, F; Smith, JP; Stanhope, CR | 1 |
| Blessing, J; Lewis, GC | 1 |
| Cześnin, K; Ploch, E; Sablińska, B | 1 |
| Banz, H; Groitl, H; Hermanek, P; Tonak, J | 1 |
| Barlow, JJ; Lele, SB; Piver, MS | 1 |
| Hunter, JA | 1 |
| Rutledge, FN; Smith, JP | 2 |
| Barlow, JJ; Chung, WS; Lee, FT; Piver, S; Vongtama, V | 1 |
| Barlow, JJ; Piver, MS | 1 |
| Håkansson, L | 1 |
| Balconi, G; Cvitkovic, E; Erba, E; Morasca, L | 1 |
| Rutledge, F; Smith, JP | 2 |
| Eidemiller, LR; Fletcher, WS; Yeager, RA | 1 |
| Barlow, JJ; Lee, FJ; Piver, MS; Vongtama, V | 1 |
| Hreshchyshyn, MM | 1 |
| Carter, RD; Krementz, ET | 1 |
| Cold, S; Pfeiffer, P; Rose, C | 1 |
| Aloe, L; Carlini, S; Cavaliere, F; Cavaliere, R; Cavallero, L; Di Filippo, F; Giannarelli, D; Moscarelli, F | 1 |
| Brusentsov, NA; Glazkova, TIu; Iavorskaia, NP; Iurchenko, NIa | 1 |
| Cumberlin, R; De Moss, E; Friedman, M; Lassus, M | 1 |
| Ishige, H; Iwasawa, H; Sekiya, S; Takamizawa, H; Tanaka, N; Tokita, H | 1 |
| Belehradek, J; Mir, LM; Orlowski, S; Paoletti, C | 1 |
| Baas, PC; Hoekstra, HJ; Oldhoff, J; Oosterhuis, JW; Schraffordt Koops, H | 1 |
| Hoekstra, HJ; Molenaar, WM; Oldhoff, J; Schraffordt Koops, H | 1 |
| Antman, KH; Ryan, LM; Siegel, RD | 1 |
| Adachi, N; Fukuma, H; Hanada, M; Ohira, M; Takayama, J | 1 |
| Hayashi, M; Kobayashi, M; Kurihara, J; Machida, M; Takahashi, H; Yamanaka, H | 1 |
| Binsack, T; Sauer, H; Wilmanns, W | 1 |
| Astrakhan, VI; Garin, AM | 1 |
| Wilms, K | 1 |
| Bierling, R | 1 |
| Gordon, RL | 1 |
| Kühböck, J | 1 |
| Kubatkina, EI; Sevast'ianova, LA; Vilenskaia, RL | 1 |
| Atanasian, LA; Savinova, VF; Toloknov, BO | 1 |
| Portugalova, VV | 1 |
| Nesković, BA | 1 |
| Astrakhan, VI; Monul, FA | 1 |
| Lemmel, EM; Motycka, K; Nouza, K; Soucek, J | 1 |
| Leĭkina, FI; Smolianskaia, AZ | 1 |
| Berenbaum, MC; Bundick, RV; Reittie, JR; Sheard, CE | 1 |
| Modest, EJ | 1 |
| Dendy, PP | 1 |
| Golomb, FM | 2 |
| Giovanella, BC; Heidelberger, C; Lohman, WA | 1 |
| Bhuyan, BK; Fraser, TJ; Scheidt, LG | 1 |
| Du Priest, RW; Fletcher, WS | 1 |
| Zubrod, CG | 1 |
| Watt, J | 1 |
| Fetherston, WC; Grueninger, AJ; Hurley, JD; Speckhard, ME | 1 |
| Rutledge, F; Smith, JP; Wharton, JT | 1 |
| Gschwind, C; Hersh, EM; McBride, CM | 1 |
| McBride, CM | 2 |
| Hall, TC; Miller, S; Nathanson, L; Schilling, A | 1 |
| Ravina, A | 1 |
| Clément, F | 1 |
| Syrkin, AB | 1 |
| Khristov, IS | 1 |
| Molteni, P; Zearo, C | 1 |
| Grabstald, H; Huvos, AG; Sharma, TC | 1 |
| Tragus, ET; Wagner, DE | 1 |
| Stehlin, JS | 1 |
| Hills, WJ; Rufino, C; Stehlin, JS | 1 |
| Hickie, RA; Meyskens, FL; Sipes, NJ; Thomson, SP | 1 |
| Cook, RL; Houghton, JA; Houghton, PJ; Lutz, PJ | 1 |
| Ghussen, F; Nagel, K | 1 |
| Freshney, RI; Kaye, SB; Merry, S | 1 |
| Creekmore, SP; Zaharko, DS | 1 |
| Afanasova, NV; Bizer, VA; Timukhina, VN | 1 |
| de Ipolyi, PD; Giovanella, BC; Greeff, PJ; Gutierrez, AE; Stehlin, JS | 1 |
| Aigner, K; Hild, P; Hundeiker, M | 1 |
| Kleinerman, ES; Muchmore, AV; Schwartz, R; Zwelling, LA | 1 |
| Ewing, JH; Kanter, PM; Karakousis, CP; Moore, R; Park, HC; Sharma, SD | 1 |
| Koops, HS; Martijn, H; Oldhoff, J | 1 |
| Martijn, H; Oldhoff, J; Schraffordt Koops, H | 1 |
| Leibson, PJ; Loken, MR; Schreiber, H; Shapiro, SJ | 1 |
| Balconi, G; D'Incalci, M; Erba, E; Garattini, S; Morasca, L; Ottolenghi, L; Salmona, A | 1 |
| Blessing, JA; Blom, J; Disaia, PJ; Lagasse, LD; Park, RC | 1 |
| Cotter, TG; Fernandes, RS | 1 |
| Bos, G; Brown, D; Fletcher, WS; Lebredo, L; Moseley, HS; Small, K; Woltering, EA | 1 |
| Powles, TJ; Smith, IE | 1 |
| Hunt, JA; Kam, PC; Shannon, KF; Thompson, JF | 1 |
| Saarinen-Pihkala, UM; Vettenranta, K; Wikström, S | 1 |
| Carli, M; Colombatti, R; Frascella, E; Koscielniak, E; Masiero, L; Oberlin, O; Pinkerton, CR; Stevens, M; Treuner, J | 1 |
| Mack, P; Wong, KP; Yang, EB; Zhang, K; Zhao, YN | 1 |
| Barnetson, RS; Bonenkamp, JJ; Damian, DL; Rose, BR; Thompson, JF | 1 |
| Ainslie, J; Finkelde, D; Henderson, MA; McKenzie, A; Mian, R; Speakman, D | 1 |
| Jovasevic, VM; Mokyr, MB | 1 |
| Anderson, JR; Barr, FG; Crist, WM; Donaldson, SS; Maurer, HM; Pappo, AS; Qualman, SJ; Raney, RB; Wiener, ES | 1 |
| Breitfeld, PP; Crist, WM; Donaldson, SS; Lobe, T; Lyden, E; Maurer, HM; Raney, RB; Ruymann, FB; Teot, LA; Wharam, M | 1 |
| Buglova, SE; Ismail-zade, RS; Potapnev, MP; Rud'ko, VS; Sachivko, NV; Semenov, AS; Shman, TV; Zhavrid, EA | 1 |
| Donepudi, M; Jovasevic, VM; Mokyr, MB; Raychaudhuri, P | 1 |
| BURKITT, D; CLIFFORD, P; OETTGEN, HF | 1 |
| ROCHLIN, DB | 2 |
| ERIDANI, S; TAGLIORETTI, D; TESTERO, S; TISO, R | 1 |
| MADEJCZYK, A; ZBORZIL, J; ZELECHOWSKA, A; ZULAWSKI, M | 1 |
| JOHNSTON, ID | 1 |
| VIGI, F | 1 |
| IGLESIAS, F; KOKAME, GM; KREMENTZ, ET | 1 |
| SAMPEY, JR | 1 |
| KNOCK, FE | 1 |
| HANDLER, AH; SARRIS, TG; WILLS, C | 1 |
| DUKAT, EG; KJELLBERG, RN; MARK, VH; SOLOWAY, AH | 1 |
| KHAN, AG | 1 |
| ROCHLIN, DB; SMART, CR | 1 |
| NAHUM, AM | 1 |
| Goto, T; Hozumi, T; Kobayashi, H; Kondo, T; Kosaku, H | 1 |
| Goehl, J; Hohenberger, W; Janssen, T; Knorr, C; Meyer, T | 1 |
| Brady, MS; Brown, K; Fisher, C; Marx, W; Patel, A | 2 |
| Hill, AD; Ryan, ER; Skehan, SJ | 1 |
| Kam, PC; Sanki, A; Thompson, JF | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Kam, PC; Kroon, HM; Moncrieff, M; Thompson, JF | 2 |
| Aloia, T; Beasley, GM; Cheng, TY; McMahon, N; Petersen, RP; Petros, W; Pruitt, SK; Sanders, G; Seigler, H; Tyler, DS; Yoo, J | 1 |
| Kam, PC; Kroon, HM; Moncrieff, MD; Scolyer, RA; Stalley, PD; Thompson, JF | 1 |
| Dunleavey, R; Gallagher, SJ; Gao, BF; Indsto, J; Kefford, RF; Lett, M; Mann, GJ; Rizos, H; Scurr, LL; Thompson, JF | 1 |
| Peach, AH; Wilks, DJ | 1 |
| Kam, PC; Kroon, HM; Lin, DY; Thompson, JF | 2 |
| Deng, L; Wu, T; Yan, X; Zhang, J | 1 |
| Andtbacka, RH; Beasley, GM; Caudle, A; Delman, KA; Grobmyer, SR; Hochwald, SN; Kane, JM; McMahon, NS; Mosca, PJ; Noyes, RD; Padussis, J; Petersen, RP; Pruitt, SK; Ross, MI; Seigler, H; Tyler, DS; Zager, JS | 1 |
| Bölling, T; Dirksen, U; Ernst, I; Jürgens, H; Ranft, A; Willich, N | 1 |
| Boesch, CE; Goehl, J; Hohenberger, W; Knorr, C; Merkel, S; Meyer, T; Waschke, L | 1 |
| Kam, PC; Thompson, JF | 1 |
| Clark, TD; Copeland, EM; Filichia, L; Grobmyer, SR; Hochwald, SN; Robinson, AR; Vaughn, K | 1 |
| Alberghini, M; Alvegard, TA; Bacci, G; Barbieri, E; Brach Del Prever, A; Capanna, R; Carli, M; Fagioli, F; Ferrari, S; Gandola, L; Luksch, R; Mapelli, S; Mercuri, M; Picci, P; Prete, A; Smeland, S; Sundby Hall, K; Tamburini, A; Tienghi, A; Wiebe, T | 1 |
| Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
| Huismans, AM; Kam, PC; Kroon, HM; Thompson, JF | 2 |
| Austin, CP; Hirota, K; Huang, R; Kono, K; Sakamuru, S; Takeda, S; Tice, RR; Witt, KL; Xia, M; Yamamoto, KN | 1 |
| Beasley, GM; Cheong, D; Delman, KA; Gonzalez, RJ; Grobmyer, SR; Kane, JM; Letson, GD; Turaga, KK; Tyler, DS; Zager, JS | 1 |
| Belli, AM; Chun, JY; Hussain, M; Powell, B | 1 |
| Beasley, GM; Chai, CY; Chen, YA; Deneve, JL; Grobmyer, SR; Hochwald, SN; Marzban, SS; Rawal, B; Tyler, DS; Zager, JS | 1 |
| Ahmad, SA; Giglia, JS; McClaine, RJ; McCoy, SJ; Sussman, JJ | 1 |
| Beasley, G; Broadwater, G; Mosca, P; Peterson, B; Raymond, AK; Sharma, K; Turley, R; Tyler, D | 1 |
| Belfort, FA; Costa, OF; Duprat Neto, JP; Facure, L; Fregnani, JH; Mauro, AC; Molina, AS; Nishinari, K; Zurstrassen, CE | 1 |
| Bui, MM; Cheong, D; Conley, A; Gonzalez, RJ; Letson, DG; Reed, D; Turaga, KK; Vohra, NA; Zager, JS | 1 |
| Deng, L; Lawrie, TA; Wu, T; Zhang, J | 1 |
| Beasley, GM; Chen, YA; Fisher, KJ; Tyler, DS; Wong, J; Zager, JS | 1 |
| Ariyan, C; Brady, MS; Rafferty, B; Steinman, J | 1 |
| Monteith, G; Parsons-Doherty, M; Poirier, VJ | 1 |
| Beasley, GM; Lee, JH; Muilenburg, DJ; Thompson, ZJ; Tyler, DS; Zager, JS | 1 |
| Beck, JF; Ebinger, M; Feuchtinger, T; Furtwängler, R; Greil, J; Handgretinger, R; Illhardt, T; Klingebiel, T; Lang, P; Schlegel, PG; Schwarze, CP | 1 |
| Athanasian, E; Brady, MS; Busam, K; Fitzgerald, MJ | 1 |
| Bashir, MR; Beasley, GM; Bhatti, L; Brys, AK; Jaffe, TA; Mosca, PJ; Nath, NS; Salama, AK; Tyler, DS | 1 |
| Barbour, A; Coventry, AG; Coventry, BJ; Giles, MH; Henderson, MA; Kroon, HM; Paddle, P; Serpell, J; Smithers, BM; Speakman, D; Sullivan, T; Thompson, JF; Wall, M | 1 |
| Ben-Shabat, I; Dossett, LA; Olofsson Bagge, R; Zager, JS | 1 |
| Bhati, R; Chen, YA; Farma, JM; Gonzalez, RJ; Hardmann, D; Kroon, HM; Mosca, PJ; Mullinax, JE; Naqvi, SM; Nath, N; O'Donoghue, C; Perez, M; Sileno, S; Thompson, JF; Zager, JS | 1 |
| Elliott, J; Finotello, R | 1 |
| Chi, Z; Cui, C; Guo, J; Kong, Y; Li, S; Lian, B; Mao, L; Sheng, X; Si, L; Tang, B; Wang, X; Yan, X | 1 |
| Amores-Fuster, I; Blackwood, L; Elliott, J; Finotello, R; Grant, IA; Harper, A; Killick, DR; Marrington, M; Mas, A; Smallwood, K; Tanis, JB | 1 |
| Barbour, A; Coventry, BJ; Henderson, MA; Kroon, HM; Serpell, J; Smithers, BM; Thompson, JF | 1 |
| Barbour, A; Beasley, GM; Carr, M; Coventry, BJ; Daou, H; Delman, KA; Farley, CR; Farma, JM; Farrow, NE; Henderson, MA; Kenyon-Smith, T; Kroon, HM; Lowe, MC; Miura, JT; Mosca, PJ; Mullen, D; Potdar, A; Serpell, J; Smithers, BM; Speakman, D; Sun, J; Teras, J; Thompson, JF; Tyler, DS; Zager, JS | 1 |
| Barbour, A; Beasley, GM; Coventry, BJ; Daou, H; Delman, KA; Farley, CR; Farma, JM; Farrow, NE; Henderson, MA; Kenyon-Smith, TJ; Kroon, HM; Lowe, MC; Miura, JT; Mosca, PJ; Mullen, D; Potdar, A; Serpell, J; Smithers, BM; Speakman, D; Sun, J; Teras, J; Thompson, JF; Tyler, DS; Zager, JS | 1 |
| Brennan, B; Fenwick, N; Gaspar, N; Gelderblom, H; Kirton, L; Laurence, V; Marec-Bérard, P; Martín-Broto, J; Moroz, V; Owens, C; Sastre, A; Strauss, S; Wheatley, K; Whelan, J | 1 |
18 review(s) available for dactinomycin and melphalan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Soviet antitumor preparations.
Topics: Animals; Antineoplastic Agents; Aziridines; Butylated Hydroxytoluene; Dactinomycin; Daunorubicin; Humans; Melphalan; Methylnitrosourea; Neoplasms, Experimental; Nitrogen Mustard Compounds; Olivomycins; Organophosphorus Compounds; Phenylalanine; Prospidium; Pyrimidines; Spiro Compounds; Streptonigrin; Tegafur; Triethylenephosphoramide; Uracil | 1977 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Mechlorethamine; Melphalan; Mercaptopurine; Methotrexate; Mice; Multiple Myeloma; Neoplasms; Prednisone; Pregnancy; Procarbazine; Time Factors; Vincristine | 1977 |
Cutaneous malignant melanoma.
Topics: Adult; Aged; Biopsy; Carmustine; Cyclophosphamide; Dactinomycin; Female; Humans; Hydroxyurea; Male; Melanoma; Melphalan; Microscopy, Electron; Middle Aged; Prognosis; Skin Neoplasms; Sunlight; Wounds and Injuries | 1976 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
Isolation perfusion for malignant melanoma of the extremity: a review.
Topics: Arm; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; Humans; Hyperthermia, Induced; Leg; Lymphatic Metastasis; Melanoma; Melphalan; Neoplasm Recurrence, Local; Neoplasm Staging | 1985 |
Isolated regional perfusion in the treatment of subungual melanoma.
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; Female; Humans; Lymph Node Excision; Male; Melanoma; Melphalan; Middle Aged; Nail Diseases; Prognosis | 1989 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, Basal Cell; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Dysgerminoma; Female; Fluorouracil; Head; Head and Neck Neoplasms; Hodgkin Disease; Humans; Injections, Intra-Arterial; Leg; Melanoma; Melphalan; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Nitrogen Mustard Compounds; Pregnancy; Sarcoma; Sarcoma, Ewing; Skin Neoplasms; Vinblastine; Wilms Tumor | 1968 |
[Burkitt's lymphoma and acute leukemias].
Topics: Acute Disease; Animals; Asparaginase; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Fluorouracil; Humans; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mice; Oncogenic Viruses; Prednisolone; Prednisone; Vincristine | 1969 |
Frequency and duration of remission after isolated limb perfusion for melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dactinomycin; Female; Follow-Up Studies; Humans; Leg; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Time Factors; Treatment Outcome | 1997 |
Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Melphalan; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Rhabdomyosarcoma; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Topotecan; Treatment Outcome; Vincristine | 2001 |
NEW AND OLD DRUGS IN THE MANAGEMENT OF HODGKIN'S DISEASE.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Dexamethasone; Folic Acid Antagonists; Hodgkin Disease; Humans; Isoniazid; Mannomustine; Melphalan; Methotrexate; Mitomycin; Mitomycins; Nitrogen Mustard Compounds; Phenylbutazone; Prednisolone; Prednisone; Thiotepa | 1964 |
NEWER ANTICANCER AGENTS.
Topics: Alkylating Agents; Antineoplastic Agents; Arsenicals; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Mechlorethamine; Melphalan; Methotrexate; Mitomycin; Mitomycins; Neoplasms; Pharmacology; Steroids; Triethylenemelamine; Vinblastine; Vincristine | 1964 |
[Soft tissue sarcoma: postoperative chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Ifosfamide; Melphalan; Mesna; Methotrexate; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Vincristine | 2004 |
Combination chemotherapy for high-risk gestational trophoblastic tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hydroxyurea; Melphalan; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine | 2009 |
Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Male; Melanoma; Melphalan; Risk Factors; Skin Neoplasms; Treatment Outcome | 2010 |
Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Early Termination of Clinical Trials; Female; Gestational Trophoblastic Disease; Humans; Hydatidiform Mole; Hydroxyurea; Leucovorin; Melphalan; Methotrexate; Pregnancy; Trophoblastic Tumor, Placental Site; Vincristine | 2013 |
Isolated limb infusion with melphalan and actinomycin D for melanoma: a systematic review.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Humans; Melanoma; Melphalan; Neoplasm Metastasis | 2014 |
22 trial(s) available for dactinomycin and melphalan
| Article | Year |
|---|---|
Combination chemotherapy for soft-tissue sarcomas: a phase III study.
Topics: Antineoplastic Agents; Clinical Trials as Topic; Cycloleucine; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Melphalan; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1979 |
Second trial drugs in ovarian cancer.
Topics: Altretamine; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Thiotepa | 1977 |
Ovarian cancer: use of multiple modality programs involving surgery, radiation therapy and chemotherapy.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Melphalan; Ovarian Neoplasms; Propionibacterium acnes; Radiotherapy Dosage | 1977 |
Chemotherapy in ovarian carcinoma recurrent after radiation therapy.
Topics: Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Middle Aged; Neoplasm Recurrence, Local; New York; Ovarian Neoplasms; Prospective Studies; Quality of Life; Thrombocytopenia | 1978 |
Primary treatment of advanced ovarian adenocarcinoma, stages III and IV.
Topics: Adenocarcinoma; Alkylating Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Thiotepa | 1975 |
Single agent vs combination chemotherapy in the treatment of ovarian cancer.
Topics: Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1977 |
Advances in chemotherapy for gynecologic cancer.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Pelvic Neoplasms; Sarcoma; Teratoma; Vincristine | 1975 |
Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; Carcinoma; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Drug Synergism; Female; Fluorouracil; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Melphalan; Middle Aged; Mitomycins; Parotid Neoplasms; Sarcoma; Urogenital Neoplasms; Vincristine | 1969 |
Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycin.
Topics: Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Erythrocyte Count; Female; Fluorouracil; Humans; Melphalan; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Platelet Count; Prognosis; Time Factors | 1980 |
MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Melphalan; Menopause; Methotrexate; Middle Aged; Mitomycin; Neoplasm Metastasis; Neoplasm Staging; Vincristine | 1993 |
High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cell Transplantation; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Epirubicin; Humans; Ifosfamide; Infant; Melphalan; Prospective Studies; Rhabdomyosarcoma; Treatment Outcome; Vincristine | 1999 |
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bronchiolitis Obliterans; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kidney Diseases; Life Tables; Male; Melphalan; Neoplasm Metastasis; Radiotherapy, Adjuvant; Remission Induction; Rhabdomyosarcoma; Sepsis; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Sarcoma; Skin Neoplasms; Treatment Outcome | 2006 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Staging; Prospective Studies; Reproducibility of Results; Skin Neoplasms; Treatment Outcome | 2008 |
Isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft-tissue sarcoma of the extremity: final report of a phase II clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brachial Artery; Catheterization, Peripheral; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Infusions, Intra-Arterial; Male; Melanoma; Melphalan; Middle Aged; Popliteal Artery; Radiography, Interventional; Remission Induction; Sarcoma | 2009 |
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Sarcoma, Ewing; Vincristine; Young Adult | 2011 |
Does increased experience with isolated limb infusion for advanced limb melanoma influence outcome? A comparison of two treatment periods at a single institution.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Follow-Up Studies; Humans; Male; Melanoma; Melphalan; Middle Aged; Skin Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 2011 |
Isolated limb infusion with hyperthermia and chemotherapy for advanced limb malignancy: factors influencing toxicity.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; Dose-Response Relationship, Drug; Extremities; Female; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Skin Neoplasms; Treatment Outcome | 2014 |
Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.
Topics: Adult; Aged; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Disease Progression; Drug Administration Schedule; Extremities; Female; Humans; Kaplan-Meier Estimate; Limb Salvage; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Staging; Prospective Studies; Retrospective Studies; Sarcoma; Skin Neoplasms; Treatment Outcome; Tumor Burden | 2014 |
The efficacy and adverse event profile of dexamethasone, melphalan, actinomycin D, and cytosine arabinoside (DMAC) chemotherapy in relapsed canine lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dactinomycin; Dexamethasone; Dog Diseases; Dogs; Female; Lymphoma; Male; Melphalan; Recurrence; Retrospective Studies | 2014 |
Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bayes Theorem; Bone Neoplasms; Busulfan; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Ifosfamide; Melphalan; Sarcoma, Ewing; Vincristine | 2022 |
138 other study(ies) available for dactinomycin and melphalan
| Article | Year |
|---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Cell-based screen for identification of inhibitors of tubulin polymerization.
Topics: Animals; Brain Neoplasms; Bucladesine; Cell Differentiation; Drug Screening Assays, Antitumor; Formazans; Glioma; Rats; Tubulin; Tumor Cells, Cultured | 1996 |
Conformational and quantitative structure-activity relationship study of cytotoxic 2-arylidenebenzocycloalkanones.
Topics: Animals; Antineoplastic Agents; Crystallography, X-Ray; Cyclohexanones; Drug Screening Assays, Antitumor; Humans; Indans; Models, Molecular; Molecular Conformation; Structure-Activity Relationship; Tetrahydronaphthalenes; Tumor Cells, Cultured | 1999 |
Sequential cytotoxicity: a theory evaluated using novel 2-[4-(3-aryl-2-propenoyloxy)phenylmethylene]cyclohexanones and related compounds.
Topics: Animals; Antineoplastic Agents; Apoptosis; Crystallography, X-Ray; Cyclohexanones; Drug Screening Assays, Antitumor; Humans; Mannich Bases; Mice; Models, Molecular; Neoplasm Proteins; RNA, Neoplasm; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Induction of morphological transformation in mouse C3H/10T1/2 clone 8 cells and chromosomal damage in hamster A(T1)C1-3 cells by cancer chemotherapeutic agents.
Topics: Antineoplastic Agents; Bleomycin; Carcinogens; Cell Transformation, Neoplastic; Cells, Cultured; Chromosomes; Cytarabine; Dactinomycin; Drug Evaluation, Preclinical; Hycanthone; Melphalan; Mercaptopurine; Methotrexate; Mutagens; Tilorone; Vincristine | 1977 |
Hyperthermia in the treatment of cancer.
Topics: Bacillus; Bacterial Toxins; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Diathermy; Evaluation Studies as Topic; Hot Temperature; Humans; Hyperthermia, Induced; Immunotherapy; Melanoma; Melphalan; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Streptococcus; X-Ray Therapy | 1979 |
The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinogens; Chlorambucil; Cyclophosphamide; Dacarbazine; Dactinomycin; Diethylnitrosamine; Female; Humans; Male; Melphalan; Mice; Mitobronitol; Mitolactol; Mitomycins; Neoplasms, Experimental; Nitrogen Mustard Compounds; Picolinic Acids; Procarbazine; Rats; Streptozocin; Uracil Mustard | 1975 |
Regression of established tumors and induction of tumor immunity by intratumor chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Carmustine; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Graft Rejection; Guinea Pigs; Injections; Injections, Intraperitoneal; Liver Neoplasms; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Neoplasm Transplantation; Neoplasms, Experimental | 1976 |
The efficacy of melphalan in the combined chemotherapy of malignant trophoblastic disease.
Topics: Adult; Dactinomycin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Melphalan; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 1976 |
A new combination chemotherapy for resistant trophoblastic disease.
Topics: Adult; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Drug Resistance; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leucovorin; Melphalan; Methotrexate; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1979 |
[Comparison of the results of single-drug and combination chemotherapy of advanced ovarian cancer after 1 year].
Topics: Antineoplastic Agents; Dactinomycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Follow-Up Studies; Humans; Melphalan; Methotrexate; Ovarian Neoplasms; Time Factors; Vincristine | 1979 |
Cytotoxics and hyperthermic perfusion: a preliminary study.
Topics: Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Drug Therapy, Combination; Extremities; Female; Hot Temperature; Humans; Male; Melanoma; Melphalan; Paralysis; Remission, Spontaneous; Sarcoma; Soft Tissue Neoplasms | 1979 |
Chemotherapy in advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1975 |
Effect of cytostatic drugs on nucleic acid synthesis in mouse thymocytes and chick embryo cells.
Topics: Animals; Antineoplastic Agents; Cells, Cultured; Chick Embryo; Cytarabine; Dactinomycin; Deoxyadenosines; Deoxyuridine; DNA; Fluorouracil; Melphalan; Methotrexate; Mice; Mice, Inbred Strains; Thymidine; Thymus Gland; Triaziquone; Tritium; Uridine; Vinblastine | 1975 |
Studies on the sensitivity of anticancer agents of normal human cells in culture.
Topics: Adult; Antineoplastic Agents; Cell Survival; Cells, Cultured; Child; Dactinomycin; Doxorubicin; Female; Humans; Male; Melphalan; Mercaptopurine; Nitrogen Mustard Compounds; Periosteum; Triaziquone | 1975 |
Multimodality therapy in the treatment of regionally inoperable melanomas and sarcomas.
Topics: Adult; Aged; BCG Vaccine; Chemotherapy, Cancer, Regional Perfusion; Dacarbazine; Dactinomycin; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Melphalan; Middle Aged; Sarcoma | 1975 |
Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy, and radiation therapy.
Topics: Adenocarcinoma; Chlorambucil; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Laparotomy; Melphalan; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms | 1975 |
Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report.
Topics: Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1975 |
Chemotherapy of rhabdomyosarcoma by regional perfusion: a case report.
Topics: Adjuvants, Pharmaceutic; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Humans; Infant; Leg; Mechlorethamine; Melphalan; Rhabdomyosarcoma | 1976 |
The role of hyperthermic perfusion in the treatment of tumors of the extremities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dactinomycin; Extracorporeal Circulation; Extremities; Humans; Hyperthermia, Induced; Melanoma; Melphalan; Neoplasm Recurrence, Local; Osteosarcoma; Sarcoma; Soft Tissue Neoplasms; Survival Rate | 1990 |
[Antineoplastic activity of combinations of cytostatics and dextran-ferrite administered to mice with leukemia P-388].
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Dactinomycin; Daunorubicin; Doxorubicin; Drug Combinations; Fluorouracil; Iron-Dextran Complex; Leukemia P388; Melphalan; Methotrexate; Mice; Tegafur | 1990 |
[A new in vitro chemosensitivity test. Individualized chemotherapy against ovarian cancer and its clinical effect].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Cisplatin; Colony-Forming Units Assay; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Nimustine; Nitrosourea Compounds; Ovarian Neoplasms; Tumor Stem Cell Assay | 1985 |
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Drug Resistance; Electroshock; In Vitro Techniques; Melphalan; Methotrexate; Mice; Netropsin | 1988 |
Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities.
Topics: Adult; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Fibrosarcoma; Follow-Up Studies; Histiocytoma, Benign Fibrous; Humans; Male; Melphalan; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1987 |
Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Lomustine; Male; Melphalan; Middle Aged; Prednisone; Prognosis; Sarcoma, Ewing; Vincristine; Vindesine | 1988 |
[Autologous bone marrow transplantation in osteosarcoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Bone Neoplasms; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Male; Melphalan; Methotrexate; Osteosarcoma; Transplantation, Autologous | 1987 |
[Case report of choriocarcinoma of testicular origin indicating marked efficacy of a combination chemotherapy of methotrexate, vincristine, actinomycin D, cyclophosphamide, adriamycin and melphalan].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Humans; Lung Neoplasms; Male; Melphalan; Methotrexate; Testicular Neoplasms; Vincristine | 1986 |
[Cytostatic polychemotherapy in the aged].
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Fluorouracil; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Risk; Vincristine | 1985 |
[Olivomycin in the therapy of malignant testicular tumors].
Topics: Adult; Antibiotics, Antineoplastic; Cyclophosphamide; Dactinomycin; Depression, Chemical; Dysgerminoma; Humans; Male; Melphalan; Methotrexate; Neoplasm Metastasis; Olivomycins; Teratoma; Testicular Neoplasms | 1970 |
[Cytostatic treatment of malignant testicular neoplasms].
Topics: Adult; Antibiotics, Antineoplastic; Chlorambucil; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Dysgerminoma; Humans; Male; Melphalan; Methotrexate; Plicamycin; Prognosis; Teratoma; Testicular Neoplasms | 1971 |
Experimental investigations on problems of the clinical use of L-asparaginase.
Topics: Animals; Antibody Formation; Antineoplastic Agents; Asparaginase; Cytarabine; Dactinomycin; Drug Resistance; Drug Synergism; Escherichia coli; Immunization; Immunosuppressive Agents; Leukemia, Experimental; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Metastasis; Neoplasm Transplantation; Podophyllin; Procarbazine; Time Factors; Vincristine | 1970 |
Chemotherapy of genitourinary malignancies.
Topics: Adenocarcinoma; Bleomycin; Carcinoma, Squamous Cell; Castration; Dactinomycin; Estrogens; Female; Humans; Kidney Neoplasms; Male; Melphalan; Nitrosourea Compounds; Phosphorus Isotopes; Plicamycin; Prostatic Neoplasms; Testicular Neoplasms; Urinary Bladder Neoplasms; Urogenital Neoplasms; Vinblastine; Vincristine | 1973 |
[Indication and achievements of after-care examinations of urologic tumors. Chemotherapeutic report].
Topics: Aftercare; Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dactinomycin; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycins; Plicamycin; Postoperative Complications; Procarbazine; Urogenital Neoplasms; Vinblastine | 1973 |
[Changes in the bone marrow cell count of mice under the combined action of ultrahigh-frequency irradiation and of antitumor preparations].
Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Cell Count; Cyclophosphamide; Dactinomycin; Dose-Response Relationship, Radiation; Electromagnetic Phenomena; Male; Melphalan; Mice; Radiation Dosage; Radiation Effects; Radiation Protection; Time Factors; Vincristine | 1974 |
[Treatment of isolated metastases from choriocarcinoma of the uterus to the lung].
Topics: Adult; Antineoplastic Agents; Choriocarcinoma; Colchicine; Dactinomycin; Daunorubicin; Female; Flavonoids; Humans; Lung Neoplasms; Melphalan; Mercaptopurine; Methotrexate; Middle Aged; Mitomycins; Neoplasm Metastasis; Olivomycins; Pneumonectomy; Pregnancy; Uterine Neoplasms; Vinblastine | 1974 |
[Histochemical data on human skin melanoma in relation to treatment].
Topics: Chemotherapy, Cancer, Regional Perfusion; Clinical Enzyme Tests; Dactinomycin; Flavonoids; Histocytochemistry; Humans; Melanoma; Melphalan; NADH, NADPH Oxidoreductases; Oxidoreductases; Phosphoric Monoester Hydrolases; Radiotherapy Dosage; Skin Neoplasms; Time Factors | 1974 |
Effect of various agents on the developmental phases of the L strain cells in vitro.
Topics: Autoradiography; Cell Division; Dactinomycin; DNA; In Vitro Techniques; L Cells; Melphalan; Nucleosides; Radiation Effects; RNA; RNA, Messenger; Tritium | 1965 |
[The combined chemotherapy of testicular tumors resistant to sarcolysin].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chlorambucil; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Drug Synergism; Dysgerminoma; Humans; Male; Melphalan; Methotrexate; Olivomycins; Teratoma; Testicular Neoplasms | 1967 |
[The influence of age and experimentally-induced disease on the tolerance of cytostatically-active materials in mice].
Topics: Age Factors; Aminopterin; Animals; Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Tolerance; Graft vs Host Disease; Immunosuppressive Agents; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mice; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Skin Transplantation; Thioguanine; Transplantation, Homologous | 1967 |
[Detection of a moderate staphylococcal phage by means of antineoplastic agents].
Topics: Aminopterin; Antibiotics, Antineoplastic; Anticholesteremic Agents; Antimetabolites; Antineoplastic Agents; Chlorambucil; Colchicine; Cyclophosphamide; Dactinomycin; Drug Resistance, Microbial; Flavonoids; Fluorouracil; Lysogeny; Mechlorethamine; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Nitrogen Mustard Compounds; Olivomycins; Staphylococcus; Staphylococcus Phages; Thiotepa; Ultraviolet Rays; Uracil; Vinblastine; Vincristine | 1970 |
The growth of human tumours in immunosuppressed mice and their response to chemotherapy.
Topics: Animals; Chlorambucil; Cyclophosphamide; Dactinomycin; Disease Models, Animal; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Immunosuppression Therapy; Male; Melphalan; Methotrexate; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Ovarian Neoplasms; Thiotepa; Thymectomy; Transplantation, Heterologous; Triaziquone; Urinary Bladder Neoplasms; Vinblastine; Vincristine | 1974 |
Formal discussion: future prospects in leukemia chemotherapy.
Topics: Animals; Dactinomycin; Floxuridine; Leukemia; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Neoplasm Metastasis; Pyrimidines; Sarcoma, Experimental; Thiotepa | 1965 |
Responses of freshly cultured tumour cells to certain selected chemotherapeutic agents.
Topics: Adenocarcinoma; Antineoplastic Agents; Chlorambucil; Colchicine; Culture Techniques; Cyclophosphamide; Dactinomycin; Female; Floxuridine; Fluorouracil; Hodgkin Disease; Humans; Melphalan; Mercaptopurine; Methotrexate; Nandrolone; Neoplasms; Nitrogen Mustard Compounds; Norethindrone; Prednisolone; Progesterone; Testosterone; Thiotepa; Uterine Neoplasms; Vinblastine | 1968 |
Perfusion and infusion chemotherapy for cancer of the head and neck.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Carotid Arteries; Catheterization; Chemotherapy, Cancer, Regional Perfusion; Cyclophosphamide; Dactinomycin; DNA; Floxuridine; Fluorouracil; Head; Humans; Infusions, Parenteral; Melphalan; Methods; Neck; Nitrogen Mustard Compounds | 1964 |
Effects of elevated temperatures and drugs on the viability of L1210 leukemia cells.
Topics: Animals; Antineoplastic Agents; Cell Line; Culture Media; Culture Techniques; Dactinomycin; Female; Floxuridine; Glyceraldehyde; Hexoses; Hot Temperature; Leukemia L1210; Melphalan; Mice; Neoplasms; Oxalates; Sodium; Vinblastine | 1970 |
Cell cycle phase specificity of antitumor agents.
Topics: Alkaloids; Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carbazoles; Cell Line; Chlorambucil; Cricetinae; Cytarabine; Dactinomycin; Depression, Chemical; DNA; Fibroblasts; Floxuridine; In Vitro Techniques; Lung; Melphalan; Mitosis; Neoplasms, Experimental; Nitrosourea Compounds; Nucleosides; Protein Biosynthesis; RNA; Streptozocin; Thiosemicarbazones | 1972 |
Chemotherapy of testicular germinal tumors.
Topics: Alkylating Agents; Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Dysgerminoma; Humans; Male; Mechlorethamine; Melphalan; Methotrexate; Nitrofurazone; Pharmaceutic Aids; Plicamycin; Prognosis; Testicular Neoplasms; Testis; Vincristine | 1973 |
Acute leukemias and Burkitt's lymphoma. Present status of therapy.
Topics: Antineoplastic Agents; Asparaginase; Burkitt Lymphoma; Choriocarcinoma; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Female; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Melphalan; Mercaptopurine; Methotrexate; Prednisone; Pregnancy; Vincristine; Wilms Tumor | 1968 |
Chemotherapy in the treatment of cancer of the ovary.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Female; Fluorouracil; Humans; Mechlorethamine; Melphalan; Ovarian Neoplasms; Thiotepa; Vinblastine | 1970 |
Integrated therapy in the treatment of ovarian cancer with surgery, radiation and chemotherapy.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Ascites; Chlorambucil; Cobalt Isotopes; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Endometriosis; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Radiotherapy, High-Energy; Thiotepa; Vinblastine; Vincristine | 1972 |
Chemotherapy of ovarian cancer. New approaches to treatment.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antineoplastic Agents; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1972 |
Metastatic ovarian cancer.
Topics: Adenocarcinoma, Mucinous; Cyclophosphamide; Cystadenocarcinoma; Dactinomycin; Drug Combinations; Female; Fluorouracil; Humans; Melphalan; Neoplasm Metastasis; Ovarian Neoplasms | 1973 |
Perfusion of melanoma. 105 isolated perfusions in 92 patients.
Topics: Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Humans; Melanoma; Melphalan; Neoplasm Recurrence, Local; Skin Neoplasms; Thiotepa | 1972 |
Local and systemic immunologic effects of perfusion therapy for malignant melanoma.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Graft Rejection; Humans; Immunosuppression Therapy; Lectins; Lymphocyte Activation; Lymphocyte Depletion; Lymphocytes; Mechlorethamine; Melanoma; Melphalan; Prognosis; Streptolysins; Stress, Physiological | 1973 |
Sarcomas of the limbs. Results of adjuvant chemotherapy using isolation perfusion.
Topics: Aged; Amputation, Surgical; Arm; Bone Neoplasms; Cartilage; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Fibrosarcoma; Hemangiosarcoma; Humans; Leg; Liposarcoma; Male; Melphalan; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma | 1974 |
[The chemotherapy of cancer].
Topics: Adult; Alkylating Agents; Antimetabolites; Antineoplastic Agents; Dactinomycin; Female; Fluorouracil; Hodgkin Disease; Humans; Lung Neoplasms; Male; Melphalan; Methotrexate; Middle Aged; Neoplasms; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Radiography; Sarcoma, Ewing; Thiotepa; Vincristine | 1967 |
[Time factor in evaluating antineoplastic agents].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Dactinomycin; Fluorouracil; Melphalan; Mercaptopurine; Methylthiouracil; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Nitrogen Mustard Compounds; Rats; Sarcoma, Experimental; Time Factors | 1972 |
[Chemotherapy of malignant testicular tumors].
Topics: Chlorambucil; Dactinomycin; Drug Synergism; Humans; Male; Melphalan; Methotrexate; Oral Manifestations; Testicular Neoplasms | 1971 |
[Oral cytology during antiblastic treatment].
Topics: Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Daunorubicin; Female; Genital Neoplasms, Female; Humans; Melphalan; Methotrexate; Mouth Mucosa | 1969 |
Advanced melanoma of the extremities.
Topics: Adolescent; Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Child; Dactinomycin; Female; Humans; Leg; Male; Mechlorethamine; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Prognosis; Skin Neoplasms | 1970 |
Retroperitoneal malignant mesenchymoma.
Topics: Adult; Aortography; Child, Preschool; Cyclophosphamide; Dactinomycin; Female; Humans; Male; Melphalan; Mesenchymoma; Middle Aged; Neoplasm Metastasis; Nephrectomy; Prednisone; Radioisotope Teletherapy; Retroperitoneal Neoplasms; Urography | 1971 |
Current therapy for postmastectomy lymphangiosarcoma.
Topics: Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Humans; Lymphangiosarcoma; Mastectomy; Melphalan; Middle Aged | 1968 |
Hyperthermic perfusion with chemotherapy for cancers of the extremities.
Topics: Arm; Burns; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Edema; Femoral Neoplasms; Foot Diseases; Hemangiosarcoma; Hemoglobinuria; Hemolysis; Hot Temperature; Humans; Leg; Melanoma; Melphalan; Neoplasm Metastasis; Sarcoma; Sarcoma, Ewing; Sarcoma, Kaposi; Time Factors | 1969 |
Disseminated melanoma. Biologic behavior and treatment.
Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Hydrazines; Hydroxyurea; Lymph Node Excision; Lymphatic Metastasis; Melanoma; Melphalan; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Perfusion; Vincristine | 1967 |
Potential biological explanation of stimulation of colony growth in semi-solid agar by cytotoxic agents.
Topics: Agar; Animals; Cell Count; Cell Division; Cell Line; Clone Cells; Cytological Techniques; Dactinomycin; Female; Humans; Melanoma; Melphalan; Mice; Stimulation, Chemical | 1983 |
Childhood rhabdomyosarcoma xenografts: responses to DNA-interacting agents and agents used in current clinical therapy.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Child; Cisplatin; Cyclophosphamide; Dacarbazine; Dactinomycin; Doxorubicin; Female; Humans; Melphalan; Mice; Mice, Inbred CBA; Mitomycin; Mitomycins; Neoplasm Transplantation; Rhabdomyosarcoma; Transplantation, Heterologous; Vincristine | 1984 |
[Regional hyperthermic cytostatic perfusion as an alternative in the treatment of malignant soft tissue tumors of the extremities].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arm; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; Female; Hot Temperature; Humans; Leg; Male; Melphalan; Middle Aged; Soft Tissue Neoplasms | 1984 |
Cross-resistance to cytotoxic drugs in human glioma cell lines in culture.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Dactinomycin; Doxorubicin; Drug Resistance; Fluorouracil; Glioma; Humans; Melphalan; Podophyllotoxin; Vincristine | 1984 |
Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light.
Topics: Animals; Cell Division; Cell Survival; Clone Cells; Dactinomycin; Hematoporphyrins; Leukemia L1210; Melphalan; Mice; Phototherapy | 1983 |
[Programs for the radiation and drug treatment of metastases of Ewing's sarcoma to the lungs in children].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carubicin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Gamma Rays; Humans; Lung Neoplasms; Melphalan; Methotrexate; Orotic Acid; Prednisolone; Radiotherapy Dosage; Sarcoma, Ewing; Time Factors; Vincristine | 1983 |
15 years' experience with hyperthermic perfusion for treatment of soft tissue sarcoma and malignant melanoma of the extremities.
Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Extremities; Humans; Hyperthermia, Induced; Injections, Intravenous; Melanoma; Melphalan; Perfusion; Sarcoma; Soft Tissue Neoplasms | 1984 |
[New modifications in isolated extremity perfusion ].
Topics: Antineoplastic Agents; Arm; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Dacarbazine; Dactinomycin; Drug Therapy, Combination; Hot Temperature; Humans; Leg; Mechlorethamine; Melanoma; Melphalan; Skin Neoplasms | 1982 |
Effect of L-phenylalanine mustard, adriamycin, actinomycin D, and 4'-(9-acridinylamino)methanesulfon-m-anisidide on naturally occurring human spontaneous monocyte-mediated cytotoxicity.
Topics: Aminoacridines; Amsacrine; Antineoplastic Agents; Cisplatin; Cytotoxicity, Immunologic; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Humans; Immunity, Innate; In Vitro Techniques; Lymphocytes; Melphalan; Monocytes | 1982 |
Tourniquet infusion versus hyperthermic perfusion.
Topics: Aged; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Dogs; Doxorubicin; Extremities; Female; Hindlimb; Humans; Infusions, Intra-Arterial; Male; Melanoma; Melphalan; Middle Aged; Sarcoma; Skin Neoplasms; Tissue Distribution; Tourniquets | 1982 |
Hyperthermic regional perfusion with melphalan and a combination of melphalan and actinomycin D in the treatment of locally metastasized malignant melanomas of the extremities.
Topics: Adult; Aged; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Drug Therapy, Combination; Extremities; Female; Hot Temperature; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1982 |
Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs.
Topics: Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Follow-Up Studies; Hot Temperature; Humans; Male; Melanoma; Melphalan; Neoplasm Recurrence, Local; Neoplasm Staging; Sex Factors | 1981 |
Direct determination of the influence of the cell cycle on the survival of tumor cells exposed to cytotoxic antibodies.
Topics: Animals; Antibodies, Neoplasm; Cell Cycle; Cell Line; Cell Survival; Dactinomycin; Immunotherapy; Melphalan; Mice; Multiple Myeloma; Neoplasms, Experimental | 1980 |
Pharmacokinetic approach to in vitro testing of ovarian cancer cell sensitivity.
Topics: Antineoplastic Agents; Cell Survival; Cytarabine; Dactinomycin; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance; Female; Fluorouracil; Half-Life; Humans; In Vitro Techniques; Melphalan; Methotrexate; Ovarian Neoplasms | 1980 |
Apoptosis or necrosis: intracellular levels of glutathione influence mode of cell death.
Topics: Alkylating Agents; Apoptosis; Camptothecin; Cell Death; Cell Line; Chlorambucil; Dactinomycin; DNA; Glutathione; Humans; Melphalan; Necrosis | 1994 |
Hyperthermic isolation limb perfusion (HILP) in the management of extremity melanoma and sarcoma with particular reference to the dosage, pharmacokinetics, and toxicity of cisplatin.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Combined Modality Therapy; Dacarbazine; Dactinomycin; Evaluation Studies as Topic; Extremities; Humans; Hyperthermia, Induced; Incidence; Melanoma; Melphalan; Neoplasm Metastasis; Osteosarcoma; Rhabdomyolysis; Skin Neoplasms; Treatment Outcome | 1993 |
Maximal preservation of renal function in patients with bilateral Wilms' tumor: therapeutic strategy of late kidney-sparing surgery and replacement of radiotherapy by high-dose melphalan and stem cell rescue.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Administration Schedule; Female; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Pilot Projects; Rhabdomyoma; Vincristine; Wilms Tumor | 1998 |
Glutathione-related factors are not correlated with sensitivity of human tumour cells to actinomycin D.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Dactinomycin; Drug Resistance, Microbial; Drug Resistance, Neoplasm; Glutathione; Humans; Melphalan; Neoplasms; Tumor Cells, Cultured | 2000 |
Treatment of refractory hand warts by isolated limb infusion with melphalan and actinomycin D.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Follow-Up Studies; Hand Dermatoses; Humans; Immunocompetence; Infusions, Intra-Arterial; Male; Melphalan; Recurrence; Severity of Illness Index; Treatment Outcome; Warts | 2001 |
Isolated limb infusion for melanoma: a simple alternative to isolated limb perfusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Humans; Infusions, Intra-Arterial; Leg; Melanoma; Melphalan; Skin Neoplasms | 2001 |
Melphalan-induced expression of IFN-beta in MOPC-315 tumor-bearing mice and its importance for the up-regulation of TNF-alpha expression.
Topics: Animals; Antineoplastic Agents, Alkylating; Cycloheximide; Dactinomycin; Female; Hydrogen Peroxide; Interferon-beta; Melphalan; Mice; Mice, Inbred BALB C; Plasmacytoma; RNA, Messenger; Tumor Necrosis Factor-alpha; Up-Regulation | 2001 |
[Salvage thermochemotherapy in advanced refractory malignant tumors in children].
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Hyperthermia, Induced; Interleukin-2; Male; Melphalan; Monitoring, Immunologic; Neoplasms; Neuroleptanalgesia; Salvage Therapy; Time Factors; Vincristine | 2002 |
Melphalan-induced up-regulation of B7-1 surface expression on normal splenic B cells.
Topics: Animals; Antineoplastic Agents, Alkylating; Antioxidants; B-Lymphocytes; B7-1 Antigen; Binding Sites; CD8-Positive T-Lymphocytes; Cell Membrane; Cell Nucleus; Dactinomycin; Flow Cytometry; Melphalan; Mice; NF-kappa B; Oxidation-Reduction; Protein Synthesis Inhibitors; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spleen; Time Factors; Transcription Factor AP-1; Up-Regulation | 2003 |
Malignant lymphoma involving the jaw in African children: treatment with alkylating agents and actinomycin D.
Topics: Alkylating Agents; Aziridines; Child; Cyclophosphamide; Dactinomycin; Humans; Jaw; Lymphoma; Mechlorethamine; Melphalan | 1963 |
The therapy of sarcomas by isolation perfusion.
Topics: Antineoplastic Agents; Dactinomycin; Humans; Melphalan; Neoplasms; Perfusion; Sarcoma | 1963 |
[EVALUATION OF THE CURRENT THERAPEUTIC TRENDS IN HODGKIN'S DISEASE. CRITICAL REVIEW AND CASUISTIC CONTRIBUTION].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Bone Marrow Transplantation; Colchicine; Cyclophosphamide; Dactinomycin; Hodgkin Disease; Mechlorethamine; Melphalan; Neoplasms; Radioisotopes; Radiotherapy, High-Energy; Triethylenemelamine; Vinblastine | 1963 |
THE TREATMENT OF BRONCHOGENIC CARCINOMA BY CHEMICAL AGENTS.
Topics: Antineoplastic Agents; Aziridines; Carcinoma, Bronchogenic; Cyclophosphamide; Dactinomycin; Fungi; Mannomustine; Melphalan; Quinones | 1963 |
THE TREATMENT OF MALIGNANT DISEASE BY REGIONAL CHEMOTHERAPY.
Topics: Antimetabolites; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Geriatrics; Head and Neck Neoplasms; Humans; Infusions, Parenteral; Melanoma; Melphalan; Methotrexate; Mouth Neoplasms; Neoplasms; Neoplasms, Muscle Tissue; Nitrogen Mustard Compounds; Sarcoma; Toxicology; Triethylenemelamine | 1963 |
[CURRENT PRACTICE IN THE TREATMENT OF TUMORS WITH INTRA-ARTERIAL INJECTIONS OF ANTINEOPLASTIC SUBSTANCES].
Topics: Aminopterin; Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Chlorambucil; Dactinomycin; Fibrosarcoma; Fluoresceins; Humans; Infusions, Parenteral; Injections, Intra-Arterial; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Melphalan; Neoplasms; Pharmacology; Thiotepa; Toxicology | 1963 |
CURRENT STATUS OF CHEMOTHERAPY OF CANCER.
Topics: Alkylating Agents; Anti-Bacterial Agents; Antineoplastic Agents; Black People; Chemotherapy, Cancer, Regional Perfusion; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Dermatologic Agents; DNA; DNA, Neoplasm; Fluorouracil; Geriatrics; Humans; Mechlorethamine; Melphalan; Methotrexate; Neoplasms; Nitrogen Mustard Compounds; Pharmacology; Thiotepa; Toxicology; Triethylenemelamine; Vinblastine; Vincristine | 1964 |
CHEMOTHERAPY STUDIES ON PRIMARY TUMOR GRAFTS AND METASTASES IN HAMSTERS AND MICE.
Topics: Antineoplastic Agents; Cricetinae; Cyclophosphamide; Dactinomycin; Melphalan; Mice; Mitomycin; Mitomycins; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Pharmacology; Research; Sarcoma; Sarcoma, Experimental; Thiotepa | 1964 |
THE THERAPY OF SARCOMAS BY ISOLATION PERFUSION.
Topics: Aorta; Aorta, Abdominal; Bone Neoplasms; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Chondrosarcoma; Dactinomycin; Dogs; Fibrosarcoma; Iliac Artery; Iliac Vein; Leiomyosarcoma; Liposarcoma; Lymphoma, Non-Hodgkin; Melphalan; Mesothelioma; Neoplasms; Neuroblastoma; Osteosarcoma; Rhabdomyosarcoma; Sarcoma; Sarcoma, Kaposi; Subclavian Artery; Vena Cava, Inferior | 1964 |
CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Brain Neoplasms; Cyclophosphamide; Dactinomycin; Ependymoma; Mannitol; Melphalan; Mice; Neoplasms; Neoplasms, Experimental; Neuroectodermal Tumors, Primitive; Pharmacology; Research; Toxicology | 1964 |
THE MULTIFOCAL LYMPHOMA SYNDROME IN AFRICAN CHILDREN IN KENYA.
Topics: Adolescent; Alkylating Agents; Antineoplastic Agents; Aziridines; Black People; Burkitt Lymphoma; Child; Cyclophosphamide; Dactinomycin; Epidemiology; Humans; Kenya; Lymphoma; Mandibular Neoplasms; Maxillary Neoplasms; Melphalan; Neoplasms; Oncogenic Viruses | 1964 |
ISOLATION PERFUSION: EVALUATION OF 249 CASES.
Topics: Chemotherapy, Cancer, Regional Perfusion; Coccidioidomycosis; Dactinomycin; Drug Hypersensitivity; Drug Therapy; Hematologic Diseases; Humans; Melanoma; Melphalan; Mycetoma; Neoplasms; Sarcoma; Sepsis; Toxicology | 1964 |
OSTEOGENIC SARCOMA OF THE MANDIBLE. REPORT OF CASE TREATED BY RADIATION AND CHEMOTHERAPY.
Topics: Bone Neoplasms; Cobalt Isotopes; Dactinomycin; Drug Therapy; Humans; Mandible; Mandibular Neoplasms; Melphalan; Methotrexate; Neoplasms; Osteomyelitis; Osteosarcoma; Pathology; Radiography; Radium; Sarcoma | 1964 |
Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Complications; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome | 2006 |
FDG PET/CT demonstrates the effectiveness of isolated limb infusion for malignant melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Fluorodeoxyglucose F18; Infusions, Intra-Arterial; Lymphatic Metastasis; Melanoma; Melphalan; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Long-term results of hyperthermic, isolated limb perfusion for melanoma: a reflection of tumor biology.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Remission Induction; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2007 |
Outcomes following isolated limb infusion for melanoma. A 14-year experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Skin Neoplasms; Survival Rate; Time Factors; Treatment Outcome | 2008 |
Isolated limb infusion for advanced soft tissue sarcoma of the extremity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Cohort Studies; Dactinomycin; Extremities; Female; Humans; Male; Melphalan; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Sarcoma; Survival Rate | 2008 |
p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Apoptosis; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Genes, p16; Genes, ras; Humans; Male; Melanoma; Melphalan; Microphthalmia-Associated Transcription Factor; Middle Aged; Mutation; Polymorphism, Single-Stranded Conformational; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric; Tumor Suppressor Protein p14ARF | 2008 |
Isolated limb infusion as a novel treatment for extensive plantar warts.
Topics: Cytotoxins; Dactinomycin; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Infusions, Parenteral; Melphalan; Middle Aged; Papillomavirus Infections; Warts | 2009 |
Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Staging; Palliative Care; Skin Neoplasms | 2009 |
Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Skin Neoplasms | 2009 |
Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Disease Progression; Female; Humans; Leg; Male; Melanoma; Melphalan; Middle Aged; Recurrence; Skin Neoplasms; Survival Analysis; Time Factors; Treatment Outcome | 2009 |
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Drug Therapy, Combination; Extremities; Female; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Multivariate Analysis; Papaverine; Retrospective Studies; Skin Neoplasms; Treatment Outcome; United States; Young Adult | 2009 |
Radiation toxicity following busulfan/melphalan high-dose chemotherapy in the EURO-EWING-99-trial: review of GPOH data.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Chemotherapy, Adjuvant; Child; Combined Modality Therapy; Cross-Sectional Studies; Dactinomycin; Dose-Response Relationship, Drug; Germany; Humans; Ifosfamide; Intestines; Lung; Melphalan; Multicenter Studies as Topic; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Registries; Retrospective Studies; Risk Factors; Sarcoma, Ewing; Spinal Cord; Survivors; Vincristine | 2009 |
Long-term outcome of hyperthermic isolated limb perfusion (HILP) in the treatment of locoregionally metastasised malignant melanoma of the extremities.
Topics: Adult; Aged; Aged, 80 and over; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Hyperthermia, Induced; Kaplan-Meier Estimate; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Skin Neoplasms; Treatment Outcome | 2010 |
Use of an automated circuit for isolated limb infusion for malignancy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Heart Arrest, Induced; Humans; Lower Extremity; Male; Melanoma; Melphalan; Middle Aged; Skin Neoplasms; Treatment Outcome | 2010 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Infratentorial Neoplasms; Irinotecan; Melphalan; Neoplasm Metastasis; Neuroblastoma; Rhabdomyosarcoma; Thiotepa; Topotecan; Vincristine | 2011 |
Characterization of environmental chemicals with potential for DNA damage using isogenic DNA repair-deficient chicken DT40 cell lines.
Topics: Acetamides; Animals; Cell Line; Chickens; Chromosome Aberrations; Dactinomycin; DNA Damage; DNA Repair-Deficiency Disorders; Doxorubicin; Lovastatin; Melphalan; Mutagenicity Tests; Mutagens; Resorcinols; Toluene | 2011 |
Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Chemotherapy, Cancer, Regional Perfusion; Creatine Kinase; Dactinomycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Length of Stay; Limb Salvage; Male; Melphalan; Middle Aged; Retrospective Studies; Sarcoma; Skin Neoplasms; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2011 |
Technique and outcomes of isolated limb infusion for locally advanced malignant melanoma--a radiological perspective.
Topics: Aged; Angiography; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Infusion Pumps; Melanoma; Melphalan; Neoplasm Staging; Postoperative Care; Preoperative Care; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2011 |
A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Drug Administration Schedule; Female; Humans; Length of Stay; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2012 |
Quality of life outcomes after isolated limb infusion.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arm; Carcinoma, Merkel Cell; Cross-Sectional Studies; Dactinomycin; Edema; Female; Follow-Up Studies; Humans; Hypesthesia; Infusions, Intravenous; Leg; Length of Stay; Male; Melanoma; Melphalan; Neoplasm Recurrence, Local; Quality of Life; Skin Neoplasms; Survival Rate | 2012 |
Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; Female; Follow-Up Studies; Humans; Hyperthermia, Induced; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Remission Induction; Survival Rate | 2012 |
The use of isolated limb infusion in limb threatening extremity sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Male; Melphalan; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2013 |
Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Dactinomycin; Extremities; Female; Follow-Up Studies; Humans; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Prognosis; Remission Induction; Retrospective Studies; Survival Rate | 2014 |
Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Humans; Leg; Male; Melanoma; Melphalan; Middle Aged; Multivariate Analysis; Neoplasm Seeding; Retrospective Studies; Skin Neoplasms | 2015 |
Children with relapsed or refractory nephroblastoma: favorable long-term survival after high-dose chemotherapy and autologous stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kidney Neoplasms; Male; Melphalan; Neoplasm Recurrence, Local; Transplantation Conditioning; Vincristine; Wilms Tumor | 2014 |
Myoepithelial carcinoma of the extremity: Response to isolated limb infusion.
Topics: Adult; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Infusions, Intravenous; Male; Melphalan; Myoepithelioma; Neoplasm Staging; Prognosis; Survival Rate | 2015 |
Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Disease Progression; Feasibility Studies; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Lower Extremity; Melanoma; Melphalan; Neoplasm Staging; Prognosis; Retrospective Studies; Skin Neoplasms; Tomography, X-Ray Computed | 2016 |
Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Australia; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Follow-Up Studies; Humans; Lower Extremity; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Skin Neoplasms; Survival Rate | 2016 |
Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Melanoma; Melphalan; Prognosis; Retrospective Studies; Skin Neoplasms; Survival Rate | 2016 |
Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Follow-Up Studies; Humans; Limb Salvage; Male; Melphalan; Middle Aged; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2017 |
A dexamethasone, melphalan, actinomycin-D and cytarabine chemotherapy protocol as a rescue treatment for feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cytarabine; Dactinomycin; Dexamethasone; Female; Lymphoma; Male; Melphalan; Salvage Therapy | 2018 |
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; China; Dactinomycin; Extremities; Female; Follow-Up Studies; Humans; Male; Melanoma; Melphalan; Middle Aged; Prospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2018 |
Evaluation of a multi-agent chemotherapy protocol combining dexamethasone, melphalan, actinomycin D, and cytarabine for the treatment of resistant canine non-Hodgkin high-grade lymphomas: a single centre's experience.
Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Dactinomycin; Databases, Factual; Dexamethasone; Dog Diseases; Dogs; Female; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Schools, Veterinary; Thrombocytopenia; Treatment Outcome; United Kingdom | 2019 |
Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Australia; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Melphalan; Middle Aged; Prospective Studies; Skin Neoplasms; Upper Extremity | 2019 |
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Australia; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Female; Humans; Length of Stay; Lower Extremity; Male; Melanoma; Melphalan; Neoplasm Metastasis; Neoplasm Staging; Neoplasm, Residual; Progression-Free Survival; Skin Neoplasms; Treatment Outcome; Tumor Burden; United States; Upper Extremity | 2020 |
Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study.
Topics: Age Factors; Aged; Aged, 80 and over; Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Australia; Chemotherapy, Cancer, Regional Perfusion; Creatine Kinase; Dactinomycin; Dose-Response Relationship, Drug; Female; Humans; Ischemia; Lower Extremity; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Sex Factors; Skin Neoplasms; Time Factors; Tourniquets; United States; Upper Extremity | 2020 |